We are proud to have reached a significant clinical milestone, having now treated our 200th patient with Arthrosamid®, a long-acting injectable treatment for people living with knee osteoarthritis.
Introduced at The Horder Centre last year, Arthrosamid® is a non-surgical treatment option designed to help reduce knee pain and improve function in suitable patients, offering an alternative for those who may not yet require surgery.
The milestone reflects our growing expertise in delivering innovative, evidence-based treatments for musculoskeletal conditions.
It is delivered in an outpatient setting by one of four specialist knee consultants, Mr Tofunmi Oni, Mr Andrew Skyrme, Mr Andrew Armitage, and Mr Christopher Buckle, who are supported by our highly skilled clinical support teams. This multidisciplinary approach ensures patients receive safe, effective and personalised care at every stage of their treatment journey.
As a CQC-rated Outstanding hospital, The Horder Centre is recognised for delivering the highest standards of safety, quality and patient experience, reinforcing its reputation as a trusted provider of specialist orthopaedic care.
Horder Healthcare’s Chief Executive Officer, Elin Richardson, said:
“Reaching our 200th Arthrosamid patient is an important milestone for the hospital, and a clear reflection of the trust patients place in our clinical teams. It demonstrates our commitment to providing innovative, non-surgical treatment options alongside the highest standards of care.
“I’m incredibly proud of our consultants and staff, whose expertise and dedication make achievements like this possible.”
We continue to invest in advanced treatments and specialist expertise to help patients manage joint pain, improve mobility, and maintain quality of life.
We are proud to have reached a significant clinical milestone, having now treated our 200th patient with Arthrosamid®, a long-acting injectable treatment for people living with knee osteoarthritis.
Introduced at The Horder Centre last year, Arthrosamid® is a non-surgical treatment option designed to help reduce knee pain and improve function in suitable patients, offering an alternative for those who may not yet require surgery.
The milestone reflects our growing expertise in delivering innovative, evidence-based treatments for musculoskeletal conditions.
It is delivered in an outpatient setting by one of four specialist knee consultants, Mr Tofunmi Oni, Mr Andrew Skyrme, Mr Andrew Armitage, and Mr Christopher Buckle, who are supported by our highly skilled clinical support teams. This multidisciplinary approach ensures patients receive safe, effective and personalised care at every stage of their treatment journey.
As a CQC-rated Outstanding hospital, The Horder Centre is recognised for delivering the highest standards of safety, quality and patient experience, reinforcing its reputation as a trusted provider of specialist orthopaedic care.
Horder Healthcare’s Chief Executive Officer, Elin Richardson, said:
“Reaching our 200th Arthrosamid patient is an important milestone for the hospital, and a clear reflection of the trust patients place in our clinical teams. It demonstrates our commitment to providing innovative, non-surgical treatment options alongside the highest standards of care.
“I’m incredibly proud of our consultants and staff, whose expertise and dedication make achievements like this possible.”
We continue to invest in advanced treatments and specialist expertise to help patients manage joint pain, improve mobility, and maintain quality of life.
We provide outstanding patient experiences
The Horder Centre is an award-winning Centre of Excellence that offers patients a unique therapeutic environment. Specifically designed for orthopaedic surgery, our facilities include a physiotherapy inpatient gym and courtyard gardens designed by clinical experts to enhance recovery. Finance options available.
Read our patient testimonials
Find out what it’s like to be a patient, from the people who matter the most.
